FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 2Y Ago
-2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -71.42% |
| Q3 2025 | 36.65% |
| Q2 2025 | 14.66% |
| Q1 2025 | 31.27% |
| Q4 2024 | 11.79% |
| Q3 2024 | 24.41% |
| Q2 2024 | 1.56% |
| Q1 2024 | 24.19% |
| Q4 2023 | 35.38% |
| Q3 2023 | 4.39% |
| Q2 2023 | 14.44% |
| Q1 2023 | 38.55% |
| Q4 2022 | -0.86% |
| Q3 2022 | 53.30% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |